Literature DB >> 12842255

Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events.

Kathleen A Foley1, Ross J Simpson, John R Crouse, Thomas W Weiss, Leona E Markson, Charles M Alexander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12842255     DOI： 10.1016/s0002-9149(03)00474-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  28 in total

1.  LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD.

Authors:  James McKenney; Christie M Ballantyne; Theodore A Feldman; William E Brady; Arvind Shah; Michael J Davies; Joanne Palmisano; Yale B Mitchel
Journal:  MedGenMed       Date:  2005-07-14

Review 2.  Myopathy in older people receiving statin therapy: a systematic review and meta-analysis.

Authors:  Roli B Iwere; Jonathan Hewitt
Journal:  Br J Clin Pharmacol       Date:  2015-07-22       Impact factor: 4.335

3.  Managing dyslipidemia in primary care with restricted access to lipid-modifying therapy.

Authors:  John T Lynch; Catherine E Cooke; Jonathan Rosen; Sanjay Gandhi; Michael F Bullano
Journal:  Am Health Drug Benefits       Date:  2010-09

4.  Impact of adherence to statins on coronary artery disease in primary prevention.

Authors:  Marie-Hélène Bouchard; Alice Dragomir; Lucie Blais; Anick Bérard; Danielle Pilon; Sylvie Perreault
Journal:  Br J Clin Pharmacol       Date:  2007-01-03       Impact factor: 4.335

5.  Development and validation of the hyperlipidemia: attitudes and beliefs in treatment (HABIT) survey for physicians.

Authors:  Kathleen A Foley; Joseph Vasey; Charles M Alexander; Leona E Markson
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

6.  Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial.

Authors:  Kevin Fitzgerald; Maria Frank-Kamenetsky; Svetlana Shulga-Morskaya; Abigail Liebow; Brian R Bettencourt; Jessica E Sutherland; Renta M Hutabarat; Valerie A Clausen; Verena Karsten; Jeffrey Cehelsky; Saraswathy V Nochur; Victor Kotelianski; Jay Horton; Timothy Mant; Joseph Chiesa; James Ritter; Malathy Munisamy; Akshay K Vaishnaw; Jared A Gollob; Amy Simon
Journal:  Lancet       Date:  2013-10-03       Impact factor: 79.321

7.  Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label, parallel-group, multicenter study (DISCOVERY Alpha study).

Authors:  Azan S Binbrek; Avishay Elis; Muayed Al-Zaibag; Jaan Eha; Irena Keber; Ada M Cuevas; Swati Mukherjee; Thomas R Miller
Journal:  Curr Ther Res Clin Exp       Date:  2006-01

8.  Missed opportunity in the treatment of hyperlipidemia in patients with coronary heart disease: the primary care setting.

Authors:  Michael H Hoskins; Terry A Jacobson
Journal:  J Natl Med Assoc       Date:  2006-01       Impact factor: 1.798

9.  Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acids.

Authors:  Paul S Phillips; Theodore P Ciaraldi; Dong-Lim Kim; M Anthony Verity; Tanya Wolfson; Robert R Henry
Journal:  Endocrine       Date:  2008-12-03       Impact factor: 3.633

10.  Prevalence, awareness, treatment, and control of high LDL cholesterol in New York City, 2004.

Authors:  Ushma D Upadhyay; Elizabeth Needham Waddell; Stephanie Young; Bonnie D Kerker; Magdalena Berger; Thomas Matte; Sonia Y Angell
Journal:  Prev Chronic Dis       Date:  2010-04-15       Impact factor: 2.830
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.